Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- NK cell diversity, KIR and HLA
- Natural killer cell functions
- NK cells controlled by receptors for HLA
- HLA are the most polymorphic human genes
- KIR gene number is variable
- KIR recognize epitopes of HLA molecules
- KIR 'A' haplotypes
- Maintenance of diversity in human populations
- Modern human history and 4 sample populations
- Two distinct African populations
- The Yucpa Amerindian population
- 2 common and distinct KIR haplotypes in Yucpa
- Two common KIR haplotypes in Europeans
- A and B KIR haplotypes in balance worldwide
- Keeping the balance
- Identifying specific amino acids
- Positive selection
- An unusually high frequency of HLA-C*07
- Two KIR2DL3 alleles are unique to the Yucpa
- Yucpa 2DL3*009 has reduced HLA-C*07 binding
- Khoisan population
- KIR2DL1-K44 is an allele unique to Khoisan
- 2DL1*022 has switched HLA binding specificity
- Extent of diversity in populations
- Understanding the extent of KIR/HLA diversity
- High KIR allelic diversity in Ghana and Khoisan
- Very high combinatorial diversity per-population
- Very high combinatorial diversity per-individual
- Individualized NK repertoire
- NK repertoire diversity as a quantitative trait
- Conclusions (1)
- KIR/HLA in ancient humans
- Denisova, Neanderthal and modern humans
- Sequences were mapped to reference genomes
- KIR/HLA are divergent in sequence and content
- Alternative mapping strategy
- Denisova has KIR A and B haplotypes
- KIR3DL1/S1 phylogenetics
- 3DS1*013 came from ancient humans
- Admixture introduced archaic haplotypes
- Conclusions (2)
- Acknowledgements (1)
- Acknowledgements (2)
Topics Covered
- NK cell Diversity; KIR and HLA
- Genetic variety of human immune systems
- Natural killer (NK) cell functions
- HLA and KIR polymorphism
- Genetic association with infectious disease
- Pregnancy syndromes
- Maintenance of diversity in populations
- KIR haplotypes, balancing selection, population bottlenecks, human population diversity
- Natural selection and functional variation, cell-free assays, allelic variants with altered specificities
- Extent of Diversity in Populations
- HLA/KIR compound genotypes and immune identity
- Distribution of viable KIR/HLA interactions
- KIR/HLA in Ancient Humans
- Virtual HLA/KIR genotype of Denisova and Neanderthal
- Distribution of ancient human KIR/HLA alleles in modern humans
Talk Citation
Norman, P. (2011, December 7). Population-specific evolution of natural killer cell diversity [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 30, 2024, from https://doi.org/10.69645/ILXZ9899.Export Citation (RIS)
Publication History
Financial Disclosures
- Dr. Paul Norman has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.